These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3506277)

  • 1. [Effect of chemotherapy with C-MOPP in Hodgkin's disease in stages III B and IV B].
    Larraín C; Cuchacovich M; Conte G
    Rev Med Chil; 1987 Sep; 115(9):842-6. PubMed ID: 3506277
    [No Abstract]   [Full Text] [Related]  

  • 2. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
    Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
    Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
    Kanaev SV; Kolygin BA; Malinin AP; Chikrizov SI
    Vopr Onkol; 1986; 32(9):53-6. PubMed ID: 3765524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of malignant lymphoma: 12 years' experience with 109 patients. 1). Treatment of Hodgkin's disease].
    Furukawa Y; Takagi S; Tsuboyama A; Akashi M; Komatsu N; Takeda K; Muroi K; Ohsaka A; Ohta M; Suda K
    Rinsho Ketsueki; 1987 Sep; 28(9):1539-43. PubMed ID: 3437515
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of radiotherapy in the treatment of Hodgkin's disease].
    Saito Y; Hirose J; Chohtoh S; Nishijima H; Kobayashi A; Kamimura R; Takashima T; Ohtake S; Yoshida T; Nakamura S
    Gan No Rinsho; 1985 Dec; 31(15):1899-904. PubMed ID: 3841562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
    Sampi K; Honda T; Hattori M
    Rinsho Ketsueki; 1984 Feb; 25(2):164-8. PubMed ID: 6547984
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of dose and rate of administration of MOPP drugs in 97 retrospective Hodgkin's patients.
    Gobbi PG; Cavalli C; Rossi A; Bertoloni D; Galeone F; Pieresca C; Grignani E
    Haematologica; 1987; 72(6):523-8. PubMed ID: 3126109
    [No Abstract]   [Full Text] [Related]  

  • 10. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's disease in children and adolescents. Experiences from the Memorial Sloan-Kettering Cancer Center, New York.
    Tan CT
    Cancer Treat Res; 1989; 41():291-302. PubMed ID: 2577084
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of Hodgkin's disease including the staging laparotomy].
    Yosida T; Nakanisi J; Kobayasi S; Ohtake S; Ito K; Nakamura S; Hattori K; Saito Y; Tanimoto K
    Rinsho Ketsueki; 1984 Jun; 25(6):827-34. PubMed ID: 6548266
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract]   [Full Text] [Related]  

  • 14. [Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].
    Błasińska-Morawiec M; Płuzańska A; Krykowski E; Robak T; Mrówka I
    Pol Arch Med Wewn; 1991 Oct; 86(4):274-80. PubMed ID: 1813880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
    J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of the results of short-term polychemotherapy by the MOPP program of Hodgkin's disease stages III and IV].
    Hansz J; Burchardt K; Komarnicki M; Trepińska E; Psuja P
    Pol Arch Med Wewn; 1984 Dec; 72(6):293-8. PubMed ID: 6549512
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.